Serum cytokine values and fatigue in chronic hepatitis C infection
Retreatment for 24 vs 48 weeks with interferon-α2b plus ribavirin of chronic hepatitis C patients who relapsed or did not respond to interferon alone
HCV RNA levels during therapy with amantadine in addition to interferon and ribavirin in chronic hepatitis C patients with previous nonresponse or response/relapse to interferon and ribavirin
Long-term follow-up of sustained responders to interferon therapy, in patients with chronic hepatitis C
The HCV National Register: towards informing the natural history of hepatitis C infection in the UK*
Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus
Haemophilic patients with hepatitis C have higher viral load compared to other well-defined patient groups
Presence of TTV DNA in serum, liver and peripheral blood mononuclear cells from patients with chronic hepatitis
Sequence variations of precore/core and precore promoter regions of hepatitis B virus in patients with or without viral reactivation during cytotoxic chemotherapy
Sequence, expression and reconstitution of an HCV genome from a British isolate derived from a single blood donation
Retinal vein thrombosis associated with chronic hepatitis C: a case series and review of the literature